Actively Recruiting

Phase Not Applicable
Age: 18Years - 54Years
All Genders
NCT07439744

NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status

Led by National Science and Technology Council, Taiwan · Updated on 2026-02-27

50

Participants Needed

1

Research Sites

143 weeks

Total Duration

On this page

Sponsors

N

National Science and Technology Council, Taiwan

Lead Sponsor

F

Fondation FondaMental

Collaborating Sponsor

AI-Summary

What this Trial Is About

A 12-week, randomized, placebo-controlled trial testing the efficacy of n-3 PUFA treatment (EPA, 2 g/day) in alleviating depressive symptoms in a subgroup of obese subjects with comorbid depression and low n-3 PUFA status (n-3 index \< 8%) (81), from the Taiwanese cohort. Associations with PLA2/COX2 genotypes, lifestyle, nutritional profiles and gut microbiota will also be determined.

CONDITIONS

Official Title

NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status

Who Can Participate

Age: 18Years - 54Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Major depressive disorder
  • Antidepressant drug-free
  • Age between 18 and 54 years
Not Eligible

You will not qualify if you...

  • Schizophrenia
  • Mania
  • Anxiety disorders (except social phobia and generalized anxiety)
  • Obsessive-compulsive disorder
  • Post-traumatic stress disorder
  • Alcohol or drug abuse/dependence (except nicotine)
  • Active suicidal ideation
  • Serious medical or neurological conditions requiring corticosteroid, non-steroidal anti-inflammatory, immunosuppressive therapies, or chronic thyroid hormone replacement

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mind Body Interface Research Center (MBI Lab & Care)

Taichung, Taichung, Taiwan, 404

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status | DecenTrialz